Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR7 | P34969 | 15/20 | 0.59 |
| ▸ | HTR1A | P08908 | 5/20 | 0.57 |
| ▸ | HTR2A | P28223 | 5/20 | 0.57 |
| ▸ | DRD2 | P14416 | 4/20 | 0.57 |
| ▸ | HTR1B | P28222 | 1/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.55 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.50 |
| ▸ | HRH1 | P35367 | 1/20 | 0.50 |
| ▸ | DRD3 | P35462 | 1/20 | 0.50 |
| ▸ | HTR2B | P41595 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6097702 | 0.90 | HTR7 (0.51) | HTR7HTR1AHTR2ADRD2HTR1B | |
| SCHEMBL6097974 | 0.85 | HTR7 (0.57) | HTR7HTR1AHTR2ADRD2HTR1B | |
| SCHEMBL6096482 | 0.81 | HTR7 (0.61) | HTR7HTR1AHTR2ADRD2HTR1B | |
| SCHEMBL6099111 | 0.80 | HTR7 (0.54) | HTR7HTR1AHTR2ADRD2HTR1B | |
| SCHEMBL12680656 | 0.80 | DRD3 (0.55) | HTR7HTR1AHTR2ADRD2KDM4E | |
| SCHEMBL6096314 | 0.78 | HTR7 (0.55) | HTR7HTR1AHTR2ADRD2HTR1B | |
| SCHEMBL6095820 | 0.77 | HTR7 (0.56) | HTR7HTR1AHTR2ADRD2HTR1B | |
| SCHEMBL6095825 | 0.77 | HTR7 (0.56) | HTR7HTR1AHTR2ADRD2HTR1B | |
| SCHEMBL1927006 | 0.75 | HTR7 (0.63) | HTR7HTR1AHTR2ADRD2KDM4E | |
| SCHEMBL6526310 | 0.75 | HTR7 (0.65) | HTR7HTR1AHTR2ADRD2SLC6A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040229864-A1 | Sulfone derivatives as 5-HT7 receptor ligands | MERCK SHARP & DOHME LTD. (GB) | 2004-11-18 | — | — | US | claimed |
| US-7101892-B2 | Sulfone derivatives as 5-HT7 receptor ligands | MERCK SHARP & DOHME LTD. | 2006-09-05 | — | — | US | disclosed |
| US-20040229864-A1 | Sulfone derivatives as 5-HT7 receptor ligands | MERCK SHARP & DOHME LTD. (GB) | 2004-11-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040229864-A1 | Sulfone derivatives as 5-HT7 receptor ligands | HTR7, HTR2C, HTR1A | HTR7 1/4885HTR1A 3/4885HTR2A 12/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.